109 related articles for article (PubMed ID: 23864996)
1. A Pilot Trial of Jawarish Amla as Adjuvant to Anti-Tubercular Treatment Drugs for Control of Adverse Reactions in DOTS Regime in Pulmonary TB.
Sherwani AM; Zulkifle M; Rehmatulla
J IMA; 2012; 44(1):. PubMed ID: 23864996
[TBL] [Abstract][Full Text] [Related]
2. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.
Upadya H; Prabhu S; Prasad A; Subramanian D; Gupta S; Goel A
BMC Complement Altern Med; 2019 Jan; 19(1):27. PubMed ID: 30670010
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study.
Kapoor MP; Suzuki K; Derek T; Ozeki M; Okubo T
Contemp Clin Trials Commun; 2020 Mar; 17():100499. PubMed ID: 31890983
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
Karkon Varnosfaderani S; Hashem-Dabaghian F; Amin G; Bozorgi M; Heydarirad G; Nazem E; Nasiri Toosi M; Mosavat SH
J Integr Med; 2018 Mar; 16(2):126-131. PubMed ID: 29526236
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of Cutaneous Adverse Drug Reactions to Anti-tubercular Drugs and Safe Therapy after Re-challenge - A Retrospective Study.
Sharma RK; Verma GK; Tegta GR; Sood S; Rattan R; Gupta M
Indian Dermatol Online J; 2020; 11(2):177-181. PubMed ID: 32477975
[TBL] [Abstract][Full Text] [Related]
7. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin.
Gopa B; Bhatt J; Hemavathi KG
Indian J Pharmacol; 2012 Mar; 44(2):238-42. PubMed ID: 22529483
[TBL] [Abstract][Full Text] [Related]
8. Adverse Drug Reaction Profile in Patients on Anti-tubercular Treatment Alone and in Combination with Highly Active Antiretroviral Therapy.
Sadiq S; Khajuria V; Tandon VR; Mahajan A; Singh JB
J Clin Diagn Res; 2015 Oct; 9(10):FC01-4. PubMed ID: 26557538
[TBL] [Abstract][Full Text] [Related]
9. Clinical Correlates and Drug Resistance in HIV-Infected and -Uninfected Pulmonary Tuberculosis Patients in South India.
Sara C; Elsa H; Baijayanti M; Lennartsdotter EM
World J AIDS; 2016 Sep; 6(3):87-100. PubMed ID: 27708985
[TBL] [Abstract][Full Text] [Related]
10. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process.
Yokozawa T; Kim HY; Kim HJ; Okubo T; Chu DC; Juneja LR
Br J Nutr; 2007 Jun; 97(6):1187-95. PubMed ID: 17506915
[TBL] [Abstract][Full Text] [Related]
11. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients.
Chen TS; Liou SY; Chang YL
Am J Chin Med; 2009; 37(1):19-25. PubMed ID: 19222108
[TBL] [Abstract][Full Text] [Related]
12. Spinal Tuberculosis - Directly Observed Treatment and Short Course or Daily Anti Tubercular Therapy -Are We Over Treating?
Banga RK; Singh J; Dahuja A; Garg RS
Open Orthop J; 2018; 12():380-388. PubMed ID: 30369990
[TBL] [Abstract][Full Text] [Related]
13. Amla (Emblica officinalis) extract is effective in preventing high fructose diet-induced insulin resistance and atherogenic dyslipidemic profile in ovariectomized female albino rats.
Koshy SM; Bobby Z; Hariharan AP; Gopalakrishna SM
Menopause; 2012 Oct; 19(10):1146-55. PubMed ID: 22692334
[TBL] [Abstract][Full Text] [Related]
14. Profile and outcome of childhood tuberculosis treated with DOTS--an observational study.
Panigatti P; Ratageri VH; Shivanand I; Madhu PK; Shepur TA
Indian J Pediatr; 2014 Jan; 81(1):9-14. PubMed ID: 23893370
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of effect of Withania somnifera as an adjuvant to DOTS in patients of newly diagnosed sputum smear positive pulmonary tuberculosis.
Kumar R; Rai J; Kajal NC; Devi P
Indian J Tuberc; 2018 Jul; 65(3):246-251. PubMed ID: 29933868
[TBL] [Abstract][Full Text] [Related]
16. The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model.
Kim HY; Okubo T; Juneja LR; Yokozawa T
Br J Nutr; 2010 Feb; 103(4):502-12. PubMed ID: 19878614
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis: a new vision for the 21st century.
Small PM
Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of Bhringarajasava as Naimittika Rasayana in Rajayakshma with special reference to pulmonary tuberculosis.
Dornala SN; Dornala SS
Ayu; 2012 Oct; 33(4):523-9. PubMed ID: 23723670
[TBL] [Abstract][Full Text] [Related]
19. Influence of amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats.
Kim HJ; Yokozawa T; Kim HY; Tohda C; Rao TP; Juneja LR
J Nutr Sci Vitaminol (Tokyo); 2005 Dec; 51(6):413-8. PubMed ID: 16521700
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
